Preliminary research indicate conolidine may inhibit distinct ion channels, lessening neuronal excitability and limiting agony indicators. This system is particularly related in neuropathic pain, where irregular signaling leads to persistent irritation. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to ache per